Understanding the characteristics of Hidradenitis Suppurativa
Clinical and Biological Characteristics of Hidradenitis Suppurativa
This study is trying to better understand the symptoms and biological features of Hidradenitis Suppurativa to help find better ways to treat people with this skin condition.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 13 Years and up |
| Sex | All |
| Sponsor | University of California, San Francisco Academic / other |
| Locations | 1 site (San Francisco, California) |
| Trial ID | NCT03967600 on ClinicalTrials.gov |
What this trial studies
This observational study aims to thoroughly characterize the clinical and biological features of Hidradenitis Suppurativa (HS), a debilitating skin condition that is often poorly understood. By enrolling patients diagnosed with HS, the study will gather data to help develop a clinical classification system and identify potential treatments. The research focuses on both the clinical manifestations and biological markers associated with HS, providing a comprehensive overview of the disease. The findings could pave the way for improved management strategies for patients suffering from this condition.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 13 years or older with a clinically confirmed diagnosis of Hidradenitis Suppurativa.
Not a fit: Patients who are unable to provide informed consent or those with chronic skin conditions unrelated to HS may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better understanding and treatment options for patients with Hidradenitis Suppurativa.
How similar studies have performed: While there is limited research specifically on Hidradenitis Suppurativa, similar observational studies in dermatology have shown promise in understanding complex skin conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
Hidradenitis Suppurativa Patients Inclusion Criteria: 1. Age 13 years or older 2. Diagnosis of HS clinically-confirmed by a physician Exclusion Criteria: 1\. Inability to give informed consent or have a parent/guardian who is able and willing to give informed consent. Healthy Volunteer Inclusion Criteria: 1. No history of chronic skin conditions 2. No recent history of antibiotic use Exclusion Criteria: 1\. Inability to give informed consent or have a parent/guardian who is able and willing to give informed consent.
Where this trial is running
San Francisco, California
- University of California, San Francisco — San Francisco, California, United States (Recruiting)
Study contacts
- Principal investigator: Haley B Naik, MD, MHSc, FAAD — University of California, San Francisco
- Study coordinator: Kaelin Chatterley
- Email: Kaelin.Chatterley@ucsf.edu
- Phone: 415-961-3786
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.